Cited by 498Sirtuins and Resveratrol in MedicineGenetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and Senescence

LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation

Open access
Simon, Matthew, Van Meter, Michael, Ablaeva, Julia, Ke, Zhonghe, Gonzalez, Raul S., Taguchi, Taketo, De Cecco, Marco, Leonova, Katerina I. +12 more·2019·Cell Metabolism

Abstract

Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs), which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6 knockout mice and completely rescued type I interferon response. In tissue culture, inhibition of L1 with siRNA or NRTIs abrogated type I interferon response, in addition to a significant reduction of DNA damage markers. These results indicate that L1 activation contributes to the pathologies of SIRT6 knockout mice. Similarly, L1 transcription, cytoplasmic cDNA copy number, and type I interferons were elevated in the wild-type aged mice. As sterile inflammation is a hallmark of aging, we propose that modulating L1 activity may be an important strategy for attenuating age-related pathologies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.02.014

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Repeated triggering of the RCM response disrupts youthful gene expression and releases retrotransposons, including those normally silenced by SIRT1 and SIRT6.

    “Studies of these proteins indicate that repeated triggering of the RCM response disrupts youthful gene expression patterns and liberates retrotransposons, such as those silenced by SIRT1/SIRT6 (De Cecco et al., 2019; Oberdoerffer et al., 2008; Simon et al., 2019).”

    From Loss of epigenetic information as a cause of mammalian aging (2023) · cites this paper as Simon et al., 2019

    The Discussion reports elevated LINE1 expression in aged wild-type and SIRT6-deficient mice and suggests that loss of silencing or redistribution of chromatin modifiers such as SIRT1 and SIRT6 may explain its activation. It does not establish that repeated triggering of an RCM response disrupts youthful gene-expression patterns or causes retrotransposon release. The indexed passages provide section labels but no page numbers. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Nucleoside reverse-transcriptase inhibitors, which block retrotransposition of transposable elements, reduce the detrimental SASP effects of senescence and improve chronic inflammation in aged animals.

    “Treatment with nucleoside reverse-transcriptase inhibitors, which inhibit retrotransposition of transposable elements, limits the senescence-associated detrimental effects of SASP and ameliorates chronic inflammation in aged animals62,119.”

    From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [119]

    In Results (‘L1 misexpression and sterile inflammation in aged mice’), d4T treatment significantly reduced type I interferons in several tissues of aged wild-type mice, supporting the inflammation claim. The paper reports only a trend toward lower plasma levels of SASP-associated cytokines, however, so the claim that treatment limits the detrimental effects of SASP is stronger than the reported finding. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In aged mouse tissues, SIRT6 is lost from L1 elements, likely due to increased recruitment to sites of oxidative DNA damage, and its overexpression opposes age-related increases of L1 expression in diverse tissues.

    “In aged mouse tissues, SIRT6 is lost from L1 elements, likely due to increased recruitment to sites of oxidative DNA damage, and its overexpression opposes age-related increases of L1 expression in diverse tissues34.”

    From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [34]

    The Results section reports that SIRT6 overexpression prevented the age-related increase in L1 transcription in aged mouse livers, but it does not establish this effect across diverse tissues. The Discussion suggests that redistribution of chromatin modifiers such as SIRT6 may contribute to L1 activation; it does not report SIRT6 loss from L1 elements in aged tissues or attribute such loss to recruitment to oxidative DNA-damage sites. No page numbers are available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Treatment with NRTIs that inhibit L1 reverse transcriptase, or knockdown of L1 expression with shRNAs against active L1 families, decreased cytoplasmic L1 DNAs and ameliorated cGAS and IFN-I activation.

    “Importantly, treatment with nucleoside reverse transcriptase inhibitor (NRTI) drugs that inhibit L1 reverse transcriptase, or a knockdown of L1 expression with shRNAs against active L1 families, decreased cytoplasmic L1 DNAs and ameliorated cGAS and IFN-I activation33, 34, 92.”

    From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [34]

    The Results sections on L1 inhibition and the interferon response report that RNAi targeting active L1 families reduced L1 RNA, while both L1 RNAi and NRTI treatment rescued IFN-α and IFN-β1 expression. The Discussion says NRTIs rescued cytoplasmic L1 accumulation, and the Results link cytoplasmic L1 DNA to cGAS signaling. Our copy does not show that L1-targeting RNAi reduced cytoplasmic L1 DNA or that either intervention directly reduced cGAS activation; those parts are stronger than the reported results (page numbers unavailable). (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Treatment of middle-aged normal mice with NRTIs retarded the progression of aging biomarkers, in particular DNA methylation age and p16INK4A expression.

    “Treatment of middle-aged normal mice with NRTIs retarded the progression of aging biomarkers, in particular DNA methylation age and p16INK4A expression34.”

    From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [34]

    The Results section (page unavailable) reports lower DNA methylation age in d4T-treated mice and a difference in the p16 reporter in female wild-type mice treated from 46 weeks of age. The p16 difference was not statistically significant in males, and the paper reports a treatment-group difference in methylation age rather than directly measuring a slower rate of progression for that biomarker. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., Neretti, N., Roichman, A., Cohen, H. Y., Meer, M. V., Gladyshev, V. N., Antoch, M. P., Gudkov, A. V., Sedivy, J. M., Seluanov, A., & Gorbunova, V.
Affiliations
  • University of Rochester (US)
  • Roswell Park Comprehensive Cancer Center (US)
  • Ariel University (IL)
  • Brown University (US)
  • Bar-Ilan University (IL)
  • Brigham and Women's Hospital (US)
Corresponding author
  • Seluanov, Andrei
  • Gorbunova, Vera
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2019-04
Volume
29
Issue
4
Pages
871-885.e5
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2921681769
Cited by
498
References
54
Citations by year
2026: 73 · 2025: 80 · 2024: 75 · 2023: 66 · 2022: 78 · 2021: 60 · 2020: 45 · 2019: 19 · 2018: 2
FWCI
26.59
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH
  • Roswell Park Alliance Foundation
  • Life Extension Foundation
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
aging, sterile inflammation, type I interferon response, cGAS, nucleoside reverse transcriptase inhibitors, DNA damage, lifespan, age-related diseases
MeSH terms
Age Factors, Animals, Female, Inflammation, Male, Mice, Inbred Strains, Thymine Nucleotides, Zidovudine, RNA-Binding Proteins, Stavudine, Mice, Knockout, Sirtuins, Mice, Dideoxynucleotides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review